Alexandre Montpetit Ph.D.
Dr. Montpetit completed his undergraduate degree at the Department of Biochemistry of the Université de Montréal. He received a Ph.D. in Biochemistryfrom the same institution in 2002 for his work on the genetics of acute lymphoblastic leukemia under Dr. Daniel Sinnett (at Ste-Justine Hospital). He then did post-doctoral research under Dr. Tom Hudson at the Montreal Genome Centre (which became the McGill University and Génome Québec Innovation Centre in 2003) where he leaded large-scale genomic projects, mostly association studies for various complex traits and the Canadian portion of the HapMap project.
Since 2006, he is the assistant scientific director of the Innovation Centre and is now also the Platform Director of the Genomics sector which involves the supervision of a team of 20 employees. Dr. Montpetit is also Adjunct Professor in the Department of Human Genetics at McGill University.
Use of Next-Generation Sequencing technology in the discovery of genetic determinants of rare and complex traits such as multiple sclerosis, pediatric cancer and neurological diseases. Other interests involve the development of methods for studying the epigenome, for completing genomes (using the PacBio instrument) and for analyzing structural variants (from high-density arrays and next-generation sequencing)